Pyxis Oncology Stock (NASDAQ: PYXS) stock price, news, charts, stock research, profile.
Open | $4.270 |
Close | - |
Volume / Avg. | 70.841K / 896.530K |
Day Range | 4.250 - 4.410 |
52 Wk Range | 1.350 - 6.850 |
Market Cap | $255.206M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 5.58% |
Days to Cover | 2.98 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Pyxis Oncology (NASDAQ: PYXS) through any online brokerage.
Other companies in Pyxis Oncology’s space includes: Zura Bio (NASDAQ:ZURA), Renovaro (NASDAQ:RENB), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY) and Inovio Pharmaceuticals (NASDAQ:INO).
The latest price target for Pyxis Oncology (NASDAQ: PYXS) was reported by HC Wainwright & Co. on Wednesday, April 10, 2024. The analyst firm set a price target for 7.00 expecting PYXS to rise to within 12 months (a possible 59.45% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Pyxis Oncology (NASDAQ: PYXS) is $4.39 last updated Today at April 26, 2024 at 12:26 PM EDT.
There are no upcoming dividends for Pyxis Oncology.
Pyxis Oncology’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Pyxis Oncology.
Pyxis Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.